RB1 and neoplasm: Palbociclib exerts its chemotherapeutic effects by inducing a G1 arrest and senescence in tumor cells with a functional RB-E2F pathway (Zhu et al., 2022b; Schoninger and Blain, 2020; Dean et al., 2010).